Jonathan C. Fox - 11 Nov 2025 Form 4 Insider Report for Edgewise Therapeutics, Inc. (EWTX)

Role: Director
Signature: /s/ John R. Moore, Attorney-in-Fact for Fox Jonathan C
Issuer symbol: EWTX
Transactions as of: 11 Nov 2025
Net transactions value: +$199,403
Form type: 4
Filing time: 13 Nov 2025, 18:04:59 UTC
Previous filing: 02 Oct 2025
Next filing: 05 Jan 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Fox Jonathan C	Director	C/O EDGEWISE THERAPEUTICS, INC., 1715 38TH STREET, BOULDER	/s/ John R. Moore, Attorney-in-Fact for Fox Jonathan C	13 Nov 2025	0001655016

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EWTX	Common Stock	Purchase	$199,403	+10,700	+82%	$18.64	23,702	11 Nov 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $18.55 to $18.65, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Content

The price reported in column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $18.55 to $18.65, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.